GLENMARK LIFE SCIENCES share price has plunged 5% and is presently trading at Rs 991.7.
Meanwhile, the BSE HEALTHCARE index is at 43,143.5 (up 0.6%).
Among the top losers in the BSE HEALTHCARE index today are Procter & Gamble Health (down 2.1%) and CAPLIN POINT (down 1.1%).
LAURUS LABS (up 2.8%) and ASTER DM HEALTHCARE (up 2.5%) are among the top gainers today.
Over the last one year, GLENMARK LIFE SCIENCES has moved up from Rs 619.8 to Rs 991.7, registering a gain of Rs 371.9 (up 60.0%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,503.7 to 43,143.5, registering a gain of 56.9% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 206.8%), Glenmark Pharma (up 123.9%) and SUVEN PHARMACEUTICALS (up 123.2%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 80,109.2 (up 0.1%).
The top gainers among the BSE Sensex today are ITC (up 3.3%) and Axis Bank (up 2.5%). The most traded stocks in the BSE Sensex are Indusind Bank and ITC.
In the meantime, NSE Nifty is at 24,393.2 . Indusind Bank and NTPC are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 64,571.9 to 80,109.2, registering a gain of 15,537.3 points (up 24.1%).
GLENMARK LIFE SCIENCES net profit fell 19.7% YoY to Rs 953 million for the quarter ended September 2024, compared to a profit of Rs 1,187 million a year ago. Net sales declined 14.9% to Rs 5,069 million during the period as against Rs 5,954 million in July-September 2023.
For the year ended March 2024, GLENMARK LIFE SCIENCES reported 0.8% increase in net profit to Rs 4,709 million compared to net profit of Rs 4,670 million during FY23. Revenue of the company grew 5.6% to Rs 22,832 million during FY24.
The current Price to earnings ratio of GLENMARK LIFE SCIENCES, based on rolling 12 month earnings, stands at 28.7.
Equitymaster requests your view! Post a comment on "GLENMARK LIFE SCIENCES Plunges 5%; BSE HEALTHCARE Index Up 0.6%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!